Cargando…

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth

BACKGROUND: Novel tuberculosis (TB) vaccines recently tested in humans have been designed to boost immunity induced by the current vaccine, Mycobacterium bovis Bacille Calmette-Guérin (BCG). Because BCG vaccination is used extensively in infants, this population group is likely to be the first in wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fletcher, Helen A, Keyser, Alana, Bowmaker, Mark, Sayles, Peter C, Kaplan, Gilla, Hussey, Greg, Hill, Adrian VS, Hanekom, Willem A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654906/ https://www.ncbi.nlm.nih.gov/pubmed/19239680 http://dx.doi.org/10.1186/1755-8794-2-10

Ejemplares similares

Association of Human TLR1 and TLR6 Deficiency with Altered Immune Responses to BCG Vaccination in South African Infants
por: Randhawa, April Kaur, et al.
Publicado: (2011)

Induction of Granulysin and Perforin Cytolytic Mediator Expression in 10-Week-Old Infants Vaccinated with BCG at Birth
por: Semple, Patricia L., et al.
Publicado: (2011)

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial
por: Hawkridge, Anthony, et al.
Publicado: (2008)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
por: Fletcher, Helen A., et al.
Publicado: (2016)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
por: Fletcher, Helen A., et al.
Publicado: (2016)

Comparison of Mantoux and Tine Tuberculin Skin Tests in BCG-Vaccinated Children Investigated for Tuberculosis
por: Pan, Wenli, et al.
Publicado: (2009)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
por: Fletcher, Helen A., et al.
Publicado: (2016)

MYCOBACTERIAL ABSCESSES AFTER BCG VACCINATION
por: Brennan, R, et al.
Publicado: (2019)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
por: Tameris, Michele, et al.
Publicado: (2013)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population
por: Yang, Qing-yuan, et al.
Publicado: (2021)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
por: Tameris, Michele D, et al.
Publicado: (2013)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
por: Naranbhai, Vivek, et al.
Publicado: (2015)

A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]
por: Elliott, Alison M, et al.
Publicado: (2005)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
por: Fletcher, Helen A., et al.
Publicado: (2008)

Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2018)

Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
por: Prabowo, Satria A., et al.
Publicado: (2019)

Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced IL-6 secretion
por: Shehu Shey, Muki, et al.
Publicado: (2010)

The Induction of Antigen 85B-Specific CD8(+) T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2023)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
por: Pathan, Ansar A., et al.
Publicado: (2007)

Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series
por: Mahdaviani, Seyed Alireza, et al.
Publicado: (2022)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
por: Pathan, Ansar A., et al.
Publicado: (2011)

Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda
por: Lule, Swaib Abubaker, et al.
Publicado: (2015)

BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model
por: Singhal, Amit, et al.
Publicado: (2011)

BCG-induced Disseminated Mycobacterial Infection of Skin and Bone in an Otherwise Immunocompetent Child
por: De, Abhishek, et al.
Publicado: (2017)

Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy
por: Gonzalez-Orozco, Maria, et al.
Publicado: (2022)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
por: Minnies, Deon, et al.
Publicado: (2008)

The Contribution of Non-Conventional T Cells and NK Cells in the Mycobacterial-Specific IFNγ Response in Bacille Calmette-Guérin (BCG)-Immunized Infants
por: Zufferey, Christel, et al.
Publicado: (2013)

The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy
por: Ru, Huanwei, et al.
Publicado: (2017)

Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
por: Deng, Guoying, et al.
Publicado: (2020)

T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis()
por: Steigler, Pia, et al.
Publicado: (2022)

Identification of Antigens Specific to Non-Tuberculous Mycobacteria: The Mce Family of Proteins as a Target of T Cell Immune Responses
por: Checkley, Anna M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_iusa445pbdcj3olsv7019ueddj